+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Transcutaneous Electrical Nerve Stimulation Market Research Report by Surgery Procedures, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4995141
  • Report
  • July 2021
  • Region: Global
  • 183 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Transcutaneous Electrical Nerve Stimulation Market will Grow to USD 374.74 Million by 2026, at a CAGR of 3.50%

FEATURED COMPANIES

  • Abbott Laboratories
  • Bioness, Inc.
  • Cogentix Medical, Inc.
  • DJO LLC.
  • EMS Physio Ltd
  • NeuroMetrix, Inc.
  • MORE
The Global Transcutaneous Electrical Nerve Stimulation Market size was estimated at USD 304.80 Million in 2020 and expected to reach USD 314.44 Million in 2021, at a Compound Annual Growth Rate (CAGR) 3.50% to reach USD 374.74 Million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Transcutaneous Electrical Nerve Stimulation to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Surgery Procedures, the Transcutaneous Electrical Nerve Stimulation Market was studied across Direct Nerve Repair, Nerve Grafting, and Stem Cell Therapy.
  • Based on Product, the Transcutaneous Electrical Nerve Stimulation Market was studied across Desktop and Portable.
  • Based on End User, the Transcutaneous Electrical Nerve Stimulation Market was studied across Clinics and Hospital.
  • Based on Region, the Transcutaneous Electrical Nerve Stimulation Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Transcutaneous Electrical Nerve Stimulation Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Transcutaneous Electrical Nerve Stimulation Market, including Abbott Laboratories, Aleva Neurotherapeutics SA, BioMedical Life Systems, Bioness, Inc., Boston Scientific Corporation, Chirag Electronics Private Limited, S.m.r.a, Cochlear Ltd, Cogentix Medical, Inc., Cyberonics, Inc., DJO LLC., ElectroCore, Inc., EMS Physio Ltd, Medtronic plc, NeuroMetrix, Inc., NeuroPace Inc, Nevro Corp, OMRON Corporation, R-slimming Medical Systems, Uroplasty, Inc., and Zynex Medical.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Transcutaneous Electrical Nerve Stimulation Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Transcutaneous Electrical Nerve Stimulation Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Transcutaneous Electrical Nerve Stimulation Market?
4. What is the competitive strategic window for opportunities in the Global Transcutaneous Electrical Nerve Stimulation Market?
5. What are the technology trends and regulatory frameworks in the Global Transcutaneous Electrical Nerve Stimulation Market?
6. What is the market share of the leading vendors in the Global Transcutaneous Electrical Nerve Stimulation Market?
7. What modes and strategic moves are considered suitable for entering the Global Transcutaneous Electrical Nerve Stimulation Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Bioness, Inc.
  • Cogentix Medical, Inc.
  • DJO LLC.
  • EMS Physio Ltd
  • NeuroMetrix, Inc.
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Surgery Procedures Outlook
3.4. Product Outlook
3.5. End User Outlook
3.6. Region Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising popularity of muscle stimulators among physiotherapists
5.1.1.2. Increasing emphasis on pain management therapies in sports medicine
5.1.1.3. Rising prevalence of musculoskeletal disorders among citizens
5.1.2. Restraints
5.1.2.1. Increased cost of nerve stimulation therapy
5.1.3. Opportunities
5.1.3.1. Rising technological advancements and modernization in the machinery used in healthcare sector
5.1.3.2. Rising research and development activities in the healthcare sector
5.1.4. Challenges
5.1.4.1. Rising lack of skilled or trained physicians
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Transcutaneous Electrical Nerve Stimulation Market, by Surgery Procedures
6.1. Introduction
6.2. Direct Nerve Repair
6.3. Nerve Grafting
6.4. Stem Cell Therapy

7. Transcutaneous Electrical Nerve Stimulation Market, by Product
7.1. Introduction
7.2. Desktop
7.3. Portable

8. Transcutaneous Electrical Nerve Stimulation Market, by End User
8.1. Introduction
8.2. Clinics
8.3. Hospital

9. Americas Transcutaneous Electrical Nerve Stimulation Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Transcutaneous Electrical Nerve Stimulation Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Thailand

11. Europe, Middle East & Africa Transcutaneous Electrical Nerve Stimulation Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Abbott Laboratories
13.2. Aleva Neurotherapeutics SA
13.3. BioMedical Life Systems
13.4. Bioness, Inc.
13.5. Boston Scientific Corporation
13.6. Chirag Electronics Private Limited, S.m.r.a
13.7. Cochlear Ltd
13.8. Cogentix Medical, Inc.
13.9. Cyberonics, Inc.
13.10. DJO LLC.
13.11. ElectroCore, Inc.
13.12. EMS Physio Ltd
13.13. Medtronic plc
13.14. NeuroMetrix, Inc.
13.15. NeuroPace Inc
13.16. Nevro Corp
13.17. OMRON Corporation
13.18. R-slimming Medical Systems
13.19. Uroplasty, Inc.
13.20. Zynex Medical

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2020 (USD MILLION)
FIGURE 3. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 4. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 5. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY REGION, 2020 (USD MILLION)
FIGURE 6. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 7. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET: MARKET DYNAMICS
FIGURE 8. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 9. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2020 VS 2026 (%)
FIGURE 10. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2020 VS 2026 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2026
FIGURE 12. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY DIRECT NERVE REPAIR, 2018-2026 (USD MILLION)
FIGURE 13. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY DIRECT NERVE REPAIR, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 14. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY NERVE GRAFTING, 2018-2026 (USD MILLION)
FIGURE 15. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY NERVE GRAFTING, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 16. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY STEM CELL THERAPY, 2018-2026 (USD MILLION)
FIGURE 17. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 18. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 19. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2026
FIGURE 21. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY DESKTOP, 2018-2026 (USD MILLION)
FIGURE 22. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY DESKTOP, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 23. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PORTABLE, 2018-2026 (USD MILLION)
FIGURE 24. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PORTABLE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 25. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 26. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2026
FIGURE 28. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY CLINICS, 2018-2026 (USD MILLION)
FIGURE 29. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY CLINICS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 30. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY HOSPITAL, 2018-2026 (USD MILLION)
FIGURE 31. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY HOSPITAL, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 32. AMERICAS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 33. ARGENTINA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 34. BRAZIL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 35. CANADA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 36. MEXICO TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 37. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 38. ASIA-PACIFIC TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 39. AUSTRALIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 40. CHINA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 41. INDIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 42. INDONESIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 43. JAPAN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 44. MALAYSIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 45. PHILIPPINES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 46. SINGAPORE TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 47. SOUTH KOREA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 48. THAILAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 49. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 50. FRANCE TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 51. GERMANY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 52. ITALY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 53. NETHERLANDS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 54. QATAR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 55. RUSSIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 56. SAUDI ARABIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 57. SOUTH AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 58. SPAIN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 59. UNITED ARAB EMIRATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 60. UNITED KINGDOM TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 61. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET: FPNV POSITIONING MATRIX
FIGURE 62. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 63. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY DIRECT NERVE REPAIR, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY NERVE GRAFTING, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY DESKTOP, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PORTABLE, BY REGION, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY CLINICS, BY REGION, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2026 (USD MILLION)
TABLE 14. AMERICAS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 15. ARGENTINA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 16. BRAZIL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 17. CANADA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 18. MEXICO TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 19. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 20. ASIA-PACIFIC TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 21. AUSTRALIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 22. CHINA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 23. INDIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 24. INDONESIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 25. JAPAN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 26. MALAYSIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. PHILIPPINES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 28. SINGAPORE TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 29. SOUTH KOREA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 30. THAILAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 31. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. FRANCE TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. GERMANY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. ITALY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. NETHERLANDS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. QATAR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. RUSSIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. SAUDI ARABIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. SOUTH AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 40. SPAIN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 41. UNITED ARAB EMIRATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 42. UNITED KINGDOM TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 43. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET: SCORES
TABLE 44. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET: BUSINESS STRATEGY
TABLE 45. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET: PRODUCT SATISFACTION
TABLE 46. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET: RANKING
TABLE 47. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 48. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET: MERGER & ACQUISITION
TABLE 49. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 50. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 51. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET: INVESTMENT & FUNDING
TABLE 52. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 53. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • BioMedical Life Systems
  • Bioness, Inc.
  • Boston Scientific Corporation
  • Chirag Electronics Private Limited, S.m.r.a
  • Cochlear Ltd
  • Cogentix Medical, Inc.
  • Cyberonics, Inc.
  • DJO LLC.
  • ElectroCore, Inc.
  • EMS Physio Ltd
  • Medtronic plc
  • NeuroMetrix, Inc.
  • NeuroPace Inc
  • Nevro Corp
  • OMRON Corporation
  • R-slimming Medical Systems
  • Uroplasty, Inc.
  • Zynex Medical
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll